Centrally Mediated Abdominal Pain Syndrome Management

Diagnostic Approach

The American Gastroenterological Association suggests that the presence of the closed eyes sign during abdominal examination is a behavioral indicator of centrally mediated pain mechanisms, prompting a shift toward neuromodulator therapy and brain-gut behavioral interventions rather than continued investigation for organic disease 1, 2
The closed eyes sign reflects hypervigilance to pain and central sensitization mechanisms, indicating that central factors are maintaining and amplifying the pain, even if peripheral factors initially triggered it 3
Complete basic laboratory workup, including complete blood count, liver function tests, and inflammatory markers, to exclude organic pathology, then stop further invasive testing once functional diagnosis is established 4
Assess for risk factors that predict chronic centrally mediated pain, such as history of prior chronic pain, early-life adversity or trauma, catastrophizing behaviors, pre-existing anxiety/depression, and negative prior pain experiences 3

The American College of Gastroenterology recommends starting low-dose tricyclic antidepressants (TCAs) as first-line neuromodulator therapy for centrally mediated abdominal pain, initiating at 10-25 mg at bedtime and titrating slowly based on response 5, 4
Offer serotonin-norepinephrine reuptake inhibitors (SNRIs) such as duloxetine if TCAs are not tolerated or for more severe symptoms, as they provide pain relief through descending pain modulation pathways 6, 7, 4
Avoid opioids completely for chronic gastrointestinal pain due to CAPS, as they worsen outcomes and risk narcotic bowel syndrome 1, 2, 4

Initiate cognitive behavioral therapy (CBT) early to address maladaptive cognitive processes, catastrophizing, and pain-related fear avoidance 1, 2, 7
Offer gut-directed hypnotherapy for patients with visceral hypersensitivity and somatic symptoms, delivered by certified clinical providers 3, 5, 4
Consider mindfulness-based stress reduction for psychological stress and negative emotion management 7, 5

Establish collaborative, empathic, culturally sensitive patient-provider relationship as the foundation of all treatment, acknowledging that pain is real and multifactorial 1, 2
Explain early that pain perception is real but involves central amplification mechanisms, not that pain is "all in their head" in a dismissive sense, but that the brain's pain processing system requires treatment 3, 4

Refer to psychologist with chronic pain experience for patients with limited response to baseline neuromodulators and self-management, or when significant psychiatric comorbidities are present 3
Consider combination neuromodulators (augmentation) for severe refractory symptoms, such as duloxetine plus gabapentin, but monitor vigilantly for serotonin syndrome (fever, hyperreflexia, tremor, sweating, diarrhea) 8

Normal HIDA scan with visualization of gallbladder, no cystic duct obstruction, and normal ejection fraction definitively excludes functional gallbladder disorder, according to the British Society of Gastroenterology 9
The British Society of Gastroenterology explicitly warns against misattribution of functional dyspepsia symptoms to gallstones, noting this leads to unnecessary surgery 9
Pain unrelated to eating argues strongly against biliary colic, which characteristically occurs 30-90 minutes postprandially 10

Between 20-50% of IBS patients have comorbid fibromyalgia; conversely, 77% of fibromyalgia patients have lifetime IBS 10
The polysymptomatic nature of symptoms indicates somatization and central amplification of visceral signals 10

The British Society of Gastroenterology specifically identifies patients with severe or refractory IBS and overlapping functional disorders as being at risk for iatrogenic harm from unnecessary surgery 11
Cholecystectomy in this setting will not resolve centrally mediated pain and may worsen symptoms through additional surgical trauma and opioid exposure 11
The narcotic bowel syndrome risk is particularly concerning given current opioid use for pain episodes 11

The British Society of Gastroenterology guideline states that iatrogenic harms due to opioid prescribing, unnecessary surgery, and unproven unregulated diagnostic or therapeutic approaches should be avoided 11
Absolutely avoid opioids, as they worsen outcomes and risk narcotic bowel syndrome in functional gastrointestinal disorders 11
IBS-specific CBT and gut-directed hypnotherapy both have strong evidence for global symptom improvement in IBS and overlapping functional disorders 11
Psychological therapies should be offered early rather than waiting 12 months, particularly given multiple comorbid functional disorders 11
Mindfulness-based stress reduction can be added for stress management 12

Establish collaborative, empathic relationship acknowledging that pain is real and multifactorial, not dismissing it as "psychological", and explain that the brain's pain processing system requires treatment, using gut-brain axis framework 13
Emphasize that cure is unlikely but substantial improvement in symptoms and quality of life is achievable with appropriate treatment 13